Filing Details
- Accession Number:
- 0001371285-21-000324
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-20 21:38:04
- Reporting Period:
- 2021-12-16
- Accepted Time:
- 2021-12-20 21:38:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1371285 | Trupanion Inc. | TRUP | Hospital & Medical Service Plans (6324) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1673762 | Tricia Plouf | C/O Trupanion, Inc. 6100 4Th Avenue South, Suite 200 Seattle WA 98108 | Co-President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-12-16 | 580 | $121.69 | 26,240 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-12-16 | 850 | $122.73 | 25,390 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-12-16 | 1,279 | $124.06 | 24,111 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-12-16 | 641 | $124.83 | 23,470 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-12-16 | 150 | $125.50 | 23,320 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on May 27, 2020 and amended on November 30, 2020, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.22 to $122.12 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.28 to $123.26 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.335 to $124.33 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.375 to $125.26 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.